Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-28 Purchase | 2024-03-29 10:39 am | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 1,882 | $11.82 | $22,242 | 5,049 (Direct) | View |
| 2022-10-06 Purchase | 2022-10-11 5:05 pm | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 33,343 | $1.2878 | $42,940 | 63,343 (Direct) | View |
| 2021-12-02 Purchase | 2021-12-02 5:09 pm | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 10,000 | $1.39 | $13,900 | 30,000 (Direct) | View |
| 2021-04-19 Purchase | 2021-04-20 7:56 pm | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 10,000 | $1.82 | $18,200 | 20,000 (Direct) | View |
| 2020-09-22 Purchase | 2020-09-22 5:14 pm | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 10,000 | $0.7245 | $7,245 | 10,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-01 Option Award | 2024-10-03 8:30 pm | N/A 2034-10-01 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 208,700 | $0 | 208,700 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-08 4:11 pm | N/A 2034-03-07 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 94,441 | $0 | 94,441 (Direct) | View |
| 2023-10-04 Option Award | 2023-10-05 5:07 pm | N/A 2033-10-04 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 358,337 | $0 | 358,337 (Direct) | View |
| 2023-03-29 Option Award | 2023-03-31 5:50 pm | N/A 2033-03-29 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 41,065 | $0 | 41,065 (Direct) | View |
| 2022-10-05 Option Award | 2022-10-07 4:39 pm | N/A 2032-10-05 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 71,998 | $0 | 71,998 (Direct) | View |
| 2022-03-23 Option Award | 2022-03-24 5:39 pm | N/A 2032-03-23 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 21,878 | $0 | 21,878 (Direct) | View |
| 2021-10-05 Option Award | 2021-10-07 5:06 pm | N/A 2031-10-05 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 47,335 | $0 | 47,335 (Direct) | View |
| 2021-03-24 Option Award | 2021-03-26 6:08 pm | N/A 2031-03-24 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 20,873 | $0 | 20,873 (Direct) | View |
| 2020-10-01 Option Award | 2020-10-05 6:47 pm | N/A 2030-10-01 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 290,372 | $0 | 450,846 (Direct) | View |
| 2020-10-05 Option Award | 2020-10-05 6:47 pm | N/A 2030-10-05 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 160,474 | $0.5141 | 450,846 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 6:06 pm | N/A 2030-07-17 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 135,000 | $0 | 135,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-20 5:52 pm | N/A 2030-03-19 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-06 8:29 pm | N/A 2030-01-02 | Outlook Therapeutics Inc. | OTLK | Haddadin Yezan Munther Director | 5,980 | $0.9853 | 5,980 (Direct) | View |